ZOLADEX

Drug TerSera Therapeutics LLC
Total Payments
$280,536
Transactions
3,108
Doctors
1,597
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2020 $12,641 127 96
2019 $63,884 1,253 649
2018 $67,703 1,003 724
2017 $136,308 725 561

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $216,252 57 77.1%
Food and Beverage $57,813 3,024 20.6%
Travel and Lodging $5,749 24 2.0%
Unspecified $638.10 2 0.2%
Education $84.00 1 0.0%

Payments by Type

General
$279,898
3,106 transactions
Research
$638.10
2 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Phase II trial of androgen deprivation therapy (ADT) and pembrolizumab for advanced stage androgen receptor-positive salivary gland carcinoma: Big Ten Cancer Research Consortium TerSera Therapeutics LLC $638.10 0

Top Doctors Receiving Payments for ZOLADEX — Page 64

Doctor Specialty Location Total Records
, M.D Hematology & Oncology Rancho Mirage, CA $10.99 1
, M.D Hematology & Oncology Union City, TN $10.98 1
, M.D Hematology & Oncology Alexandria, LA $10.96 1
, MD Emergency Medicine Camden, NJ $10.92 1
, M.D Student in an Organized Health Care Education/Training Program Johns Creek, GA $10.92 1
, M.D Hematology Tampa, FL $10.92 1
, M.D Internal Medicine Tampa, FL $10.92 1
, MD Hematology & Oncology Springfield, MO $10.90 1
, MD Medical Oncology Port Charlotte, FL $10.90 1
, MD Internal Medicine Columbia, MO $10.88 1
, MD Radiation Oncology Lewisville, TX $10.88 1
, M.D Hematology & Oncology Rancho Mirage, CA $10.82 1
, M.D Hematology & Oncology Encinitas, CA $10.80 1
, MD Internal Medicine Irving, TX $10.79 1
, DO Surgery Sterling Heights, MI $10.75 1
, D.O Urology Livonia, MI $10.75 1
, MD Hematology & Oncology Fairfield, OH $10.60 1
, M. D Hematology & Oncology Monroe, LA $10.57 1
, D. O Specialist Monroe, LA $10.57 1
, MD Internal Medicine Goshen, NY $10.56 1
, M.D Radiation Oncology Zephyrhills, FL $10.48 1
, M.D Medical Oncology Spring Hill, FL $10.48 1
, MD Hematology & Oncology Shreveport, LA $10.35 1

About ZOLADEX

ZOLADEX is a drug associated with $280,536 in payments to 1,597 healthcare providers, recorded across 3,108 transactions in the CMS Open Payments database. The primary manufacturer is TerSera Therapeutics LLC.

Payment data is available from 2017 to 2020. In 2020, $12,641 was paid across 127 transactions to 96 doctors.

The most common payment nature for ZOLADEX is "Consulting Fee" ($216,252, 77.1% of total).

ZOLADEX is associated with 1 research study, including "Phase II trial of androgen deprivation therapy (ADT) and pembrolizumab for advanced stage androgen receptor-positive salivary gland carcinoma: Big Ten Cancer Research Consortium" ($638.10).